Literature DB >> 12138114

Crystal structure of the Apo, unactivated insulin-like growth factor-1 receptor kinase. Implication for inhibitor specificity.

Sanjeev Munshi1, Maria Kornienko, Dawn L Hall, John C Reid, Lloyd Waxman, Steven M Stirdivant, Paul L Darke, Lawrence C Kuo.   

Abstract

The x-ray structure of the unactivated kinase domain of insulin-like growth factor-1 receptor (IGFRK-0P) is reported here at 2.7 A resolution. IGFRK-0P is composed of two lobes connected by a hinge region. The N-terminal lobe of the kinase is a twisted beta-sheet flanked by a single helix, and the C-terminal lobe comprises eight alpha-helices and four short beta-strands. The ATP binding pocket and the catalytic center reside at the interface of the two lobes. Despite the overall similarity to other receptor tyrosine kinases, three notable conformational modifications are observed: 1) this kinase adopts a more closed structure, with its two lobes rotated further toward each other; 2) the conformation of the proximal end of the activation loop (residues 1121-1129) is different; 3) the orientation of the nucleotide-binding loop is altered. Collectively, these alterations lead to a different ATP-binding pocket that might impact on inhibitor designs for IGFRK-0P. Two molecules of IGFRK-0P are seen in the asymmetric unit; they are associated as a dimer with their ATP binding clefts facing each other. The ordered N terminus of one monomer approaches the active site of the other, suggesting that the juxtamembrane region of one molecule could come into close proximity to the active site of the other.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12138114     DOI: 10.1074/jbc.M205580200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

Review 1.  Emerging importance of ALK in neuroblastoma.

Authors:  Anna M Azarova; Gargi Gautam; Rani E George
Journal:  Semin Cancer Biol       Date:  2011-09-16       Impact factor: 15.707

2.  Autoinhibition of the insulin-like growth factor I receptor by the juxtamembrane region.

Authors:  Barbara P Craddock; Christopher Cotter; W Todd Miller
Journal:  FEBS Lett       Date:  2007-06-19       Impact factor: 4.124

3.  Allosteric IGF-1R Inhibitors.

Authors:  Timo Heinrich; Ulrich Grädler; Henning Böttcher; Andree Blaukat; Adam Shutes
Journal:  ACS Med Chem Lett       Date:  2010-05-18       Impact factor: 4.345

4.  The insulin and IGF1 receptor kinase domains are functional dimers in the activated state.

Authors:  M Zulema Cabail; Shiqing Li; Eric Lemmon; Mark E Bowen; Stevan R Hubbard; W Todd Miller
Journal:  Nat Commun       Date:  2015-03-11       Impact factor: 14.919

5.  Expression and purification of functional insulin and insulin-like growth factor 1 holoreceptors from mammalian cells.

Authors:  Richard J Delle Bovi; W Todd Miller
Journal:  Anal Biochem       Date:  2017-08-19       Impact factor: 3.365

6.  Identifying three-dimensional structures of autophosphorylation complexes in crystals of protein kinases.

Authors:  Qifang Xu; Kimberly L Malecka; Lauren Fink; E Joseph Jordan; Erin Duffy; Samuel Kolander; Jeffrey R Peterson; Roland L Dunbrack
Journal:  Sci Signal       Date:  2015-12-01       Impact factor: 8.192

7.  The R1275Q neuroblastoma mutant and certain ATP-competitive inhibitors stabilize alternative activation loop conformations of anaplastic lymphoma kinase.

Authors:  Linda F Epstein; Hao Chen; Renee Emkey; Douglas A Whittington
Journal:  J Biol Chem       Date:  2012-08-29       Impact factor: 5.157

8.  Targeting of the protein interaction site between FAK and IGF-1R.

Authors:  Donghang Zheng; Elena Kurenova; Deniz Ucar; Vita Golubovskaya; Andrew Magis; David Ostrov; William G Cance; Steven N Hochwald
Journal:  Biochem Biophys Res Commun       Date:  2009-08-05       Impact factor: 3.575

9.  Small-molecule inhibition and activation-loop trans-phosphorylation of the IGF1 receptor.

Authors:  Jinhua Wu; Wanqing Li; Barbara P Craddock; Kenneth W Foreman; Mark J Mulvihill; Qun-sheng Ji; W Todd Miller; Stevan R Hubbard
Journal:  EMBO J       Date:  2008-06-19       Impact factor: 11.598

Review 10.  The insulin receptor: both a prototypical and atypical receptor tyrosine kinase.

Authors:  Stevan R Hubbard
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-03-01       Impact factor: 10.005

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.